Home › Hodgkin Lymphoma › New York › Queens
Hodgkin Lymphoma clinical trials in Queens, NY
4 studies for Hodgkin Lymphoma are looking for participants at sites in and around Queens (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
RecruitingPhase 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi away
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
RecruitingPhase 1
- NYU Langone Hospital - Long Island, Mineola · 11 mi away
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
RecruitingPhase 2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi away
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
RecruitingObservational study
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi away
About Hodgkin Lymphoma
Hodgkin lymphoma is a type of lymphoma, cancer of the lymph system. It is serious but can usually be cured if found and treated early. Learn more.
More about Hodgkin Lymphoma on MedlinePlus
Hodgkin Lymphoma trials in other cities
- Houston, TX14 studies
- New York City, NY11 studies
- Baldwin Park, CA9 studies
- Boston, MA9 studies
- Miami, FL8 studies
- Memphis, TN7 studies
- Philadelphia, PA6 studies
- Atlanta, GA5 studies
- Mountain View, CA5 studies
- Greenburgh, NY5 studies
- Durham, NC4 studies
- Milwaukee, WI4 studies
Other studies in Queens
- Breast Cancer64 studies
- Non-Small Cell Lung Cancer49 studies
- Colorectal Cancer31 studies
- Metastatic Cancer28 studies
- Ovarian Cancer28 studies
- Prostate Cancer27 studies
- Cancer (all types)26 studies
- Endometrial Cancer25 studies
- Lung Cancer22 studies
- Acute Myeloid Leukemia21 studies
- Multiple Myeloma20 studies
- Pancreatic Cancer20 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.